|
Heparin
Citations 71-80 of 88 total displayed.
|
Past content
(since Nov 2000):
|
- Basic Science Reports
Antithrombin-Heparin Covalent Complex: A Possible Alternative to Heparin for Arterial Thrombosis Prevention
- Anthony K.C. Chan, Janusz Rak, Leslie Berry, Peng Liao, Michal Vlasin, Jeffrey Weitz, and Petr Klement
Circulation 2002;106:261-265; published online before print as doi:10.1161/01.CIR.0000021431.88095.78
[Abstract]
[Full text]
- Corrections
Correction for vol. 105, p. 1642
-
Circulation 2002;105:2799, doi:10.1161/01.CIR.0000021758.17853.FD
[Full text]
- Clinical Investigations and Reports
Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction: Results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial
- Elliott M. Antman, Hans W. Louwerenburg, Hubert F. Baars, Jan C.L. Wesdorp, Bas Hamer, Jean-Pierre Bassand, Frederique Bigonzi, Ghislaine Pisapia, C. Michael Gibson, Hein Heidbuchel, Eugene Braunwald, Frans Van de Werf for the ENTIRE-TIMI 23 Investigators
Circulation 2002;105:1642-1649; published online before print as doi:10.1161/01.CIR.0000013402.34759.46
[Abstract]
[Full text]
- Clinician Update
Oral Anticoagulation for Acute Coronary Syndromes
- Marc A. Brouwer and Freek W.A. Verheugt
Circulation 2002;105:1270-1274, doi:10.1161/hc1102.105594
[Full text]
- Clinical Investigations and Reports
Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction: Results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial
- Elliott M. Antman, Hans W. Louwerenburg, Hubert F. Baars, Jan C.L. Wesdorp, Bas Hamer, Jean-Pierre Bassand, Frederique Bigonzi, Ghislaine Pisapia, C. Michael Gibson, Hein Heidbuchel, Eugene Braunwald, and Frans Van de Werf
Circulation published March 4, 2002, doi:10.1161/01.CIR.0000013402.34759.46
[Abstract]
[Full text]
- Basic Science Reports
In Vitro and In Vivo Evaluation of Oral Heparin–Loaded Polymeric Nanoparticles in Rabbits
- Yuyan Jiao, Nathalie Ubrich, Monique Marchand-Arvier, Claude Vigneron, Maurice Hoffman, Thomas Lecompte, and Philippe Maincent
Circulation 2002;105:230-235, doi:10.1161/hc0202.101988
[Abstract]
[Full text]
- Basic Science Reports
Conjugation of Low-Molecular-Weight Heparin and Deoxycholic Acid for the Development of a New Oral Anticoagulant Agent
- Yong-kyu Lee, Jong Hee Nam, Ho-Chul Shin, and Youngro Byun
Circulation 2001;104:3116-3120, doi:10.1161/hc5001.100627
[Abstract]
[Full text]
- Basic Science Reports
Oral Heparin Prevents Neointimal Hyperplasia After Arterial Injury: Inhibitory Potential Depends on Type of Vascular Injury
- Frederick G.P. Welt, T. Cooper Woods, and Elazer R. Edelman
Circulation 2001;104:3121-3124, doi:10.1161/hc5001.100837
[Abstract]
[Full text]
- Correspondence
Defining the Optimal Activated Clotting Times During Percutaneous Coronary Intervention: Aggregate Results From 6 Randomized, Controlled Trials • Response
- G. Helft, F. Beygui, C. le Feuvre, J. P. Metzger, Derek P. Chew, Deepak L. Bhatt, A. Michael Lincoff, David J. Moliterno, Sorin J. Brener, Katherine E. Wolski, and Eric J. Topol
Circulation 2001;104:e124
[Full text]
- Correspondence
Optimal Activated Clotting Time During Percutaneous Coronary Intervention • Response
- Colm G. Hanratty, Michael Ward, Derek P. Chew, Deepak L. Bhatt, A. Michael Lincoff, David J. Moliterno, Sorin J. Brener, Katherine E. Wolski, and Eric J. Topol
Circulation 2001;104:e83-84e
[Full text]
|
|
